ClinicalTrials.Veeva

Menu

The Effect of Chronic Anemia on Safety Period of Tracheal Intubation in Gynecology Patients

Fudan University logo

Fudan University

Status

Completed

Conditions

Chronic Anemia

Treatments

Biological: pre-oxygen

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

  1. Every individual receiving a general anesthetic is at potential risk for developing a ''cannot intubate-cannot ventilate'' situation following anesthetic induction.
  2. Building up of oxygen reserves assumes great significance as this provides a longer duration of non-hypoxic apnea should one be faced with an unanticipated difficult airway.
  3. The main physiological functions of red blood cell hemoglobin are to deliver oxygen to the peripheral tissues.
  4. During anemia, a reduction in blood oxygen content occurs as a result of reduced Hb while arterial oxygenation and oxyhemoglobin saturation remain high.
  5. Previous studies about the duration of non-hypoxic apnoea focus on methods to improve the safety period of tracheal intubation.
  6. To our knowledge, there is no literature about the duration of non-hypoxic apnoea of anemia patients.
  7. The aim of this study was to assess the effect of chronic anemia on the duration of non-hypoxic apnoea during induction of anaesthesia.

Full description

After breathing for 3 minutes, anesthesia induction was conducted. The endotracheal tube position was confirmed after anesthesia induction. Patients were left apneic with the endotracheal tube open to room air. The non-hypoxic apneic period was recorded as the time (in seconds) taken for the drop in pulse saturation to 90% or an apneic period of 10 min elapsed, whichever was earlier.

Enrollment

45 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. patients scheduled to undergo general anesthesia
  2. American Society of Anesthesiologists Performance Status 1-2
  3. adults

Exclusion criteria

  1. Individuals with significant cardiorespiratory or cerebrovascular disease,
  2. difficult intubation
  3. history of epilepsy
  4. body mass index >25 kg/m2,
  5. and those who had smoking history in past 6 months

Trial design

Primary purpose

Health Services Research

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

45 participants in 3 patient groups

Group A
Experimental group
Description:
the hemoglobin is \>12g/L in patients from group A.
Treatment:
Biological: pre-oxygen
Group B
Experimental group
Description:
Hb 9-12g/L
Treatment:
Biological: pre-oxygen
Group C
Experimental group
Description:
Hb\<9g/L
Treatment:
Biological: pre-oxygen

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems